OpenAlex
PricingAboutJobs
Log inGet started
Work

Preclinical and Clinical Development of the Cyclin-Dependent Kinase Inhibitor Flavopiridol

HTML

Year: 2004
Type: review
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-040020
Author: Geoffrey I. Shapiro
Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
Language: English

Topic: Cancer-related Molecular Pathways
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: flavopiridol, cyclin-dependent kinase inhibitors, cell cycle arrest, apoptosis, gemcitabine, docetaxel, non-small cell lung cancer, solid tumors, drug dosing schedule, combination chemotherapy
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Awards: SPORE in Lung Cancer, Cyclin-Dependent Kinase Inhibition During S Phase
OpenAlex ID: W2129581056
FWCI: 2.674
Cites: 55
Cited by: 214
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms